رجوع
نطاق اليوم
KWD 11.42
KWD 12.12
نطاق 52 أسبوعًا
KWD 5.28
KWD 21.73
حجم التداول
3,806,100
متوسط 50 يوم / 200 يوم
KWD 13.42
/
KWD 10.12
الإغلاق السابق
KWD 11.76
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -10.7 | 0.4 |
| P/B | 4.2 | 2.9 |
| ROE % | -55.6 | 3.8 |
| Net Margin % | -478.3 | 3.9 |
| Rev Growth 5Y % | 1.1 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue grew 1.06% annually over 5 years — modest growth
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -187.49M
Revenue growth is decelerating — 1Y growth trails 5Y average by 61.61%
Capital efficient — spends only 1.68% of revenue on capex
النمو
Revenue Growth (5Y)
1.06%
Revenue (1Y)-60.55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-55.56%
ROIC-29.69%
Net Margin-478.33%
Op. Margin-504.09%
الأمان
Debt / Equity
0.03
Current Ratio6.47
Interest Coverage0.00
التقييم
P/E Ratio
-10.70
P/B Ratio4.16
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60.55% | Revenue Growth (3Y) | -38.59% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 42.73M | Net Income (TTM) | -204.38M |
| ROE | -55.56% | ROA | -32.01% |
| Gross Margin | 79.28% | Operating Margin | -504.09% |
| Net Margin | -478.33% | Free Cash Flow (TTM) | -187.49M |
| ROIC | -29.69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 6.47 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.70 | P/B Ratio | 4.16 |
| P/S Ratio | 51.20 | PEG Ratio | -0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.19B | Enterprise Value | 1.60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 42.73M | 108.30M | 113.31M | 3.65M | 40.96M |
| Net Income | -204.38M | -97.01M | -57.51M | -161.82M | -122.25M |
| EPS (Diluted) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 |
| Gross Profit | 33.88M | 108.30M | 113.31M | 3.65M | 40.96M |
| Operating Income | -215.38M | -110.40M | -68.00M | -162.72M | -127.02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 638.50M | 352.21M | 274.95M | 146.39M | 207.01M |
| Total Liabilities | 112.27M | 142.69M | 235.32M | 191.48M | 174.51M |
| Shareholders' Equity | 526.23M | 209.52M | 39.63M | -45.09M | 32.50M |
| Total Debt | 17.77M | 25.40M | 32.12M | 37.61M | 29.92M |
| Cash & Equivalents | 602.07M | 302.08M | 200.35M | 88.50M | 150.56M |
| Current Assets | 614.81M | 320.39M | 235.37M | 98.54M | 162.56M |
| Current Liabilities | 95.07M | 110.95M | 186.44M | 71.52M | 64.20M |